04/08/2026
We’re taking a closer look at Foundayo™ (orforglipron), the upcoming oral GLP-1/GIP receptor agonist from Eli Lilly. Unlike traditional treatments that require injections, this daily pill offers incredible flexibility. Take it anytime, with or without food.
Whether it's blood glucose control or weight management, this medical innovation is all about making health advocacy more accessible and convenient.